It is evident that the role of phenoxybenzamine as an alpha adrenergic blocking agent is suspect in the sense that it, in concert with some other alpha adrenergic blocking agents, may display a low degree of specificity." 2 Other alpha adrenergic blocking agents the specificity of which has been questioned include bretylium and guanethidine. They have been described as exerting, in doses of from 10 to 30 times that for adrenergic nerve blockade, a curarelike (which is to say, an antinicotinic) action in cholinergic systems.3' 4 These latter two agents, considered by some as seemingly less controversial than phenoxybenzamine, will be discussed in a subsequent paper.' In the meanwhile, and for present purposes, it is well to bear in mind that controversy exists concerning phenoxybenzamine.
The reasons for using alpha adrenergic blocking agents in connection with study-of transmission to, and chemical action on, sweat glands are simple. Cholinergic innervation of the sweat glands is established beyond peradventure. 6 And yet the glands respond by secretion to injected noradrenaline, the action not being blocked by atropine, the anticholinergic (muscarinic) blocking agent that is so effective in blocking action by sudomotor impulses, injected acetylcholine, and injected pilocarpine.7 8 An account of events leading to the foregoing statement is given in reference 9. Granting, as one must, that noradrenaline acts, the problem is to attempt evaluation of its role, if any, in neuroglandular transmission. It is to this end that alpha adrenergic blocking agents have been employed.
In commenting on their study of the cholinergic blocking action of antiadrenergic agents, Boyd et al."0 stress their view that "the use of autonomic drugs as analytical tools is not reliable unless combined with both histochemical examination of the preparation and assay of the substances released upon stimulation of the nerves." This is more easily said than done. In fact, the last-mentioned condition for reliability, at least insofar as the sweat glands are concerned, seemingly is a priori impossible, for inextricably intermeshed with the sweat glands are other structures, adrenergically innervated, that could with equal justification be designated the origins of released adrenergic transmitter, supposing this were to be recovered for assay. Such a problem did not face Dale and Feldberg in establishing acetylcholine as the/a transmitter to sweat glands.6 If, then, one accepts the strictures of Boyd et al.,'0 it follows that the observations in this and subsequent papers on adrenergic blocking agents cannot be construed as constituting irrefutable evidence for an adrenergic step in the sudomotor innervation of sweat glands. Nevertheless, the question of such a step in sweat gland innervation is raised and must be considered a possible, even possibly a probable, aspect of the largely confused general picture of autonomic transmission and transmitters. Presumably the strictures would be less rigorous, but the interpretation still equivocal, had not the role of cholinergy been demonstrated. The preparations were cats anesthetized by the use of intraperitoneal chloralose (40 mg/kg) and urethane (0.8 mg/kg). Zinc-zinc sulphate electrodes were placed one upon the surface of the central foot pad, the other subcutaneously at a short distance from the first. These led to a d-c amplifier and recorder. For sudomotor stimulation the plantar nerves were isolated, centrally severed, fitted with stimulating electrodes, and submerged in a mineral oil bath. Phenoxybenzamine was slowly infused intravenously with the aid of a Harvard infusion pump. Total dosage varied between 10 and 22 mg/kg delivered over a period extending to 45 minutes or more. Admittedly the higher doses might have been too high to allow one to discount the possibility of cholinergic blockade. However, the effect of phenoxybenzamine was established, although not completed, by the time that from 3.5 to 7.5 mg/kg had been infused. In addition, as the ensuing results show, the phenoxybenzamine blockade, at least with respect to considerations of adrenergy, is not located at the same site as is the established cholinergic blockade by atropine. There is, then, circumstantial evidence of an adrenergic step in transmission to sweat glands which is, naturally, subject to the uncertainty that always befogs circumstantial evidence.
Action on Transmission.- Figure 1 illustrates the experimental procedure and the influence of phenoxybenzamine. The upward deflections are "galvanic skin responses" elicited by single stimuli to the plantar nerves iterated at intervals of 25 seconds, stimulation having begun up to an hour before recording to stabilize the level of response. Infusion began at the beginning of the top record. There is a considerable latent period for the onset of phenoxybenzamine effect occasioned in part presumably by the slow rate of infusion, although delayed onset of action also must be considered, due presumably to the necessity for in vivo formation of active intermediates." The latter cause could be of great significance in the present type of experiment. Figure 1 is presented principally to illustrate the nature of the experiment and of the raw data obtained. Figure 2 illustrates Comment.--In view of the prevailing climate of opinion concerning the action(s) of phenoxybenzamine, it would be folly to state baldly that the foregoing results demonstrate an adrenergic step in sudomotor transmission. Still, noradrenaline does activate sweat glands, and phenoxybenzamine, whatever else it may be, is an adrenergic blocking agent, and it does prevent the action on sweat glands of noradrenaline (and of nerve impulses and acetylcholine). The concept of an adrenergic step thus is worth consideration and continued study despite the ambiguities and inability to comply fully with all the experimental desiderata for establishing, as distinct from postulating, a given transmitter substance.
On a number of occasions a dual transmitter mechanism has been postulated, with acetylcholine the agent in one stage, or indeed in both stages.'3-'5 In these instances quoted it has been the curare-sensitive nicotinic action of acetylcholine that is, or at least may be, involved. The plantar nerve-sweat gland system, assuming the postulation of duality of transmitters, is unique among hypothetical dual transmitter systems in that action of the cholinergic step is muscarinocholinergic rather than nicotinocholinergic. In consideration of the foregoing it is noteworthy that a clean-cut block of sympathetic action, with the parasympathetic action unaffected, has been reported in situations involving the muscarinic action of the transmitter substance."6 The case for adrenergy in sudomotor innervation may not be as weak as to some it might appear at first glance.
Two observed facts remain to be considered and commented upon. The first of these is that the antimuscarinocholinergic agent, atropine, rapidly blocks sudomotor transmission and the action upon sweat glands of injected acetylcholine, but does not interfere with the effect of injected noradrenaline.7 8 The second is that the antiadrenergic agent phenoxybenzamine blocks all three modes of activation: by nerve impulses, by acetylcholine, and by noradrenaline. These facts constitute a demonstration, in classical terms, that the two blocking agents act upon different receptor sites. This is so whether-or -not one adopts a dual-transmitter hypothesis. However, since one might reasonably suppose-an antiadrenergic agent in high dosage, by virtue of low specificity, to block cholinoceptive receptor sites, so one should at the same time equally reasonably expect the fact that different sites are involved to mean that the adrenergic blocking agent is not effective by reason of an anticholinergic (in this case antimuscarinocholinergic) action.
Adopting pro tem a aual hypothesis, it follows from the observations on blockade that the action of acetylcholine and of noradrenaline would have to be located serially rather than in parallel, and that the cholinergic step would have to antecede the adrenergic step. 
